FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid

FOXC1, a transcription factor involved in cell differentiation and embryogenesis, is demonstrated to be a negative regulator of Nanog in this study. FOXC1 is up-regulated in retinoic acid-induced differentiation of F9 Embryonal Carcinoma (EC) cells; furthermore, FOXC1 specifically inhibits the core pluripotency factor Nanog by binding to the proximal promoter. Overexpression of FOXC1 in F9 or knockdown in 3T3 results in the down-regulation or up-regulation of Nanog mRNA and proteins, respectively. In order to explain the mechanism by which FOXC1 inhibits Nanog expression, we identified the co-repressor HDAC2 from the FOXC1 interactome. FOXC1 recruits HDAC2 to Nanog promoter to decrease H3K27ac enrichment, resulting in transcription inhibition of Nanog. To the best of our knowledge, this is the first report that FOXC1 is involved in the epigenetic regulation of gene expression.

• Publication year

  2021

• Venue

  International Journal of Molecular Sciences

• Publication date

  2021-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/ijms22052255PMID 33668324PMCID 7956269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p38‐regulated FOXC1 stability is required for colorectal cancer metastasis

  2020cited by this paper
• The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma

  2020cited by this paper
• NANOG expression in human development and cancerogenesis

  2020cited by this paper
• Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells

  2020cited by this paper
• SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer

  2020cited by this paper
• The Diverse Consequences of FOXC1 Deregulation in Cancer

  2019cited by this paper
• JASPAR 2020: update of the open-access database of transcription factor binding profiles

  2019cited by this paper
• FOXH1 Is Regulated by NANOG and LIN28 for Early-stage Reprogramming

  2019cited by this paper
• Two Opposing Faces of Retinoic Acid: Induction of Stemness or Induction of Differentiation Depending on Cell-Type

  2019cited by this paper
• The roles of microRNAs in epigenetic regulation.

  2019cited by this paper
• STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

  2018cited by this paper
• AnimalTFDB 3.0: a comprehensive resource for annotation and prediction of animal transcription factors

  2018cited by this paper
• LIN28A activates the transcription of NANOG in dairy goat male germline stem cells

  2018cited by this paper
• Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression

  2018cited by this paper
• Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a

  2018cited by this paper
• Nanog induced intermediate state in regulating stem cell differentiation and reprogramming

  2018cited by this paper
• Lyar-Mediated Recruitment of Brd2 to the Chromatin Attenuates Nanog Downregulation Following Induction of Differentiation.

  2018cited by this paper
• Structural and mechanistic insights into UHRF1-mediated DNMT1 activation in the maintenance DNA methylation

  2018cited by this paper
• The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.

  2018cited by this paper
• The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect

  2018cited by this paper
• Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma

  2018cited by this paper
• Comprehensive Proteomic Analysis of PGC7-Interacting Proteins.

  2017influential reference
• Epigenetic regulation of gene expression in cancer: techniques, resources and analysis

  2017cited by this paper
• Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression

  2017cited by this paper
• The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer

  2017cited by this paper
• FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

  2017cited by this paper
• FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles

  2017cited by this paper
• Retinoic Acid Signaling in P19 Stem Cell Differentiation.

  2017cited by this paper
• Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal

  2017cited by this paper
• The deubiquitinase USP21 maintains the stemness of mouse embryonic stem cells via stabilization of Nanog

  2016cited by this paper
• DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover

  2016cited by this paper
• Forkhead Box C1 Regulates Human Primary Keratinocyte Terminal Differentiation

  2016cited by this paper
• All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K/AKT/GSK3β signalling pathway.

  2016cited by this paper
• Gene of the month: NANOG

  2015cited by this paper
• The interactions of genes, age, and environment in glaucoma pathogenesis.

  2015cited by this paper
• RAR/RXR binding dynamics distinguish pluripotency from differentiation associated cis-regulatory elements

  2015cited by this paper
• Regulation of NANOG in cancer cells

  2015cited by this paper
• RBBP4 Regulates Histone Deacetylation and Bipolar Spindle Assembly During Oocyte Maturation in the Mouse1

  2015cited by this paper
• Retinoic Acid Induces Embryonic Stem Cell Differentiation by Altering Both Encoding RNA and microRNA Expression

  2015cited by this paper
• Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics

  2015cited by this paper
• The Role of Retinoic Acid (RA) in Spermatogonial Differentiation

  2015cited by this paper
• INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development.

  2014cited by this paper
• Vitamin C Enhances Nanog Expression Via Activation of the JAK/STAT Signaling Pathway

  2014cited by this paper
• Nanog is dispensable for the generation of induced pluripotent stem cells.

  2014cited by this paper
• Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.

  2014cited by this paper
• Retinoic acid and cancer treatment

  2014cited by this paper
• Regulatory Role of the JNK-STAT1/3 Signaling in Neuronal Differentiation of Cultured Mouse Embryonic Stem Cells

  2014cited by this paper
• Retinoic acid influences the embryoid body formation in mouse embryonic stem cells by induction of caspase and p38 MAPK/JNK‐mediated apoptosis

  2013cited by this paper
• Vitamin C facilitates pluripotent stem cell maintenance by promoting pluripotency gene transcription.

  2013cited by this paper
• UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9

  2013cited by this paper
• Epigenetic Regulation of Nanog by MiR‐302 Cluster‐MBD2 Completes Induced Pluripotent Stem Cell Reprogramming

  2013cited by this paper
• Dynamic distribution of HDAC1 and HDAC2 during mitosis: Association with F‐actin

  2013cited by this paper
• Co-localization of NANOG and OCT4 in human pre-implantation embryos and in human embryonic stem cells

  2012cited by this paper
• Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb

  2012cited by this paper
• FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells

  2011cited by this paper
• Structure and function of WD40 domain proteins

  2011cited by this paper
• The Human Epigenome Browser at Washington University

  2011cited by this paper
• Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics

  2011cited by this paper
• Nanog Overcomes Reprogramming Barriers and Induces Pluripotency in Minimal Conditions

  2011cited by this paper
• Histone methylation by PRC2 is inhibited by active chromatin marks.

  2011cited by this paper
• Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells

  2011cited by this paper
• NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.

  2011cited by this paper
• FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells

  2011cited by this paper
• Nanog Is the Gateway to the Pluripotent Ground State

  2009cited by this paper
• Sequential chromatin immunoprecipitation protocol: ChIP-reChIP.

  2009cited by this paper
• Nucleosome destabilization in the epigenetic regulation of gene expression

  2008cited by this paper
• Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFκB and cooperating with Stat3

  2008cited by this paper
• Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis.

  2008cited by this paper
• Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells.

  2008cited by this paper
• Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells

  2007cited by this paper
• Nanog safeguards pluripotency and mediates germline development

  2007cited by this paper
• Nanog and transcriptional networks in embryonic stem cell pluripotency

  2007cited by this paper
• Regulation of FOXC1 Stability and Transcriptional Activity by an Epidermal Growth Factor-activated Mitogen-activated Protein Kinase Signaling Cascade*

  2006cited by this paper
• Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis.

  2006cited by this paper
• CDC2L5, a Cdk‐like kinase with RS domain, interacts with the ASF/SF2‐associated protein p32 and affects splicing in vivo

  2006cited by this paper
• FOXC1 Transcriptional Regulatory Activity Is Impaired by PBX1 in a Filamin A-Mediated Manner

  2005cited by this paper
• Transcriptional Regulation of Nanog by OCT4 and SOX2*

  2005cited by this paper
• The pluripotency homeobox gene NANOG is expressed in human germ cell tumors

  2005cited by this paper
• Anterior segment development relevant to glaucoma.

  2004cited by this paper
• Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro.

  2004cited by this paper
• Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

  2003cited by this paper
• Fox's in development and disease.

  2003cited by this paper
• The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

  2003cited by this paper
• An automated method for finding molecular complexes in large protein interaction networks

  2003cited by this paper
• Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

  2003cited by this paper
• FOXC1 Transcriptional Regulation Is Mediated by N- and C-terminal Activation Domains and Contains a Phosphorylated Transcriptional Inhibitory Domain*

  2002cited by this paper
• A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye.

  2001cited by this paper
• The splicing factor‐associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation

  1999cited by this paper
• Pleiotropic skeletal and ocular phenotypes of the mouse mutation congenital hydrocephalus (ch/Mf1) arise from a winged helix/forkhead transcriptionfactor gene.

  1999cited by this paper
• Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.

  1998cited by this paper
• The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus.

  1998cited by this paper
• The origin and efficient derivation of embryonic stem cells in the mouse.

  1997cited by this paper
• The F9-EC cell line as a model for the analysis of differentiation.

  1991cited by this paper
• The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?

  1990cited by this paper
• Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.

  1989cited by this paper
• Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

  1981cited by this paper
• Establishment in culture of pluripotential cells from mouse embryos

  1981cited by this paper
• The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

  1970cited by this paper

• Dexmedetomidine Inhibits Ferroptosis to Alleviate Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Regulating the HDAC2/FPN Pathway

  2025cites this paper
• Di-Genic Inheritance in Genodermatoses: Insights from Two Consanguineous Cases in a Reference Lebanese Center within the Middle East and North Africa (MENA) Region

  2025cites this paper
• Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer

  2025cites this paper
• Hypercholesterolemia as a Causal Risk Factor for COPD: Biomarker Discovery and Therapeutic Implications From NHANES Data

  2025cites this paper
• Mechanism of histone deacetylase HDAC2 in FOXO3-mediated trophoblast pyroptosis in preeclampsia

  2023cites this paper
• The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers.

  2021cites this paper